About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT04753034

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

This Phase 2 study will assess efficacy, safety, and tolerability of TER-101 ointment and vehicle twice daily for 28 days in adult and adolescent subjects with mild to moderate atopic dermatitis.

Lead sponsor: Teres Bio, Inc.•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Teres Bio, Inc.

Age

12 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adolescent or adult subject aged 12 - 65 years.
•Overall IGA score of 2 (mild) or 3 (moderate) at baseline on a 5-point IGA

Exclusion Criteria

•AD with known hypersensitivity to excipients of TER-101 Ointment
•Subjects who are immunocompromised

Related studies

RECRUITINGPhase 2

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

NCT07223697 · Atopic Dermatitis

RECRUITINGPhase 1

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more

Natural History and Genetics of Food Allergy and Related Conditions

NCT02504853 · Food Allergy, Loeys-Dietz Syndrome, and more

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

NCT04455906 · Atopic Dermatitis

RECRUITINGPhase 2

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

NCT07355075 · Eczema Atopic Dermatitis, Eczema, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 26, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment63

Start dateJan 2021

Last updatedJul 26, 2022

Condition

Atopic Dermatitis

Locations shown

Teres Bio site 05

Scottsdale, Arizona

Teres Bio Site 04

Encinitas, California

Teres Bio Site 12

North Miami Beach, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 26, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions